http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20694066

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 538
issn 1381-6128
issueIdentifier 4
pageRange 527-538
publicationName Current Pharmaceutical Design
startingPage 527
bibliographicCitation Petersen P. Ximelagatran--a promising new drug in thromboembolic disorders. Curr Pharm Des. 2005;11(4):527–38. doi: 10.2174/1381612053382016. PMID: 15725069.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d45e37bcc7e6fc0e0f048bb033d5b11c
date 2005-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.2174/1381612053382016
https://pubmed.ncbi.nlm.nih.gov/15725069
isPartOf https://portal.issn.org/resource/ISSN/1381-6128
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21197
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Ximelagatran - A Promising New Drug in Thromboembolic Disorders
discusses http://id.nlm.nih.gov/mesh/M0021424
http://id.nlm.nih.gov/mesh/M0388208
http://id.nlm.nih.gov/mesh/M0284314
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0009451
http://id.nlm.nih.gov/mesh/M0002072
http://id.nlm.nih.gov/mesh/M0002392
http://id.nlm.nih.gov/mesh/M0017642
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000925Q000493
http://id.nlm.nih.gov/mesh/D001384Q000493
http://id.nlm.nih.gov/mesh/D013917Q000037
http://id.nlm.nih.gov/mesh/D013923Q000517
http://id.nlm.nih.gov/mesh/D005998Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011355
http://id.nlm.nih.gov/mesh/D001384Q000627
http://id.nlm.nih.gov/mesh/D001596
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D000925Q000627
http://id.nlm.nih.gov/mesh/D005998Q000627
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D020521Q000517
http://id.nlm.nih.gov/mesh/D005998Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D020246Q000517
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73101855
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7559
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9022
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478933
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3667f6a0c97490758d7dc9659d01ea34
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93971978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID183797

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127735632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245255101

Total number of triples: 65.